Elder Granger - 10 Nov 2021 Form 4 Insider Report for Better Therapeutics, Inc.

Role: Director
Signature: /s/ Mark Heinen, Attorney-in-Fact
Issuer symbol: BTTX on OTC
Transactions as of: 10 Nov 2021
Net transactions value: $0
Form type: 4
Filing time: 15 Nov 2021, 16:17:35 UTC
Previous filing: 05 Oct 2021
Next filing: 02 Dec 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BTTX	Stock Option (Right to Buy)	Award	$0	+28,300		$0.000000	28,300	10 Nov 2021	Common Stock	28,300	$10.14	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option vests as to 1/3 of the shares subject to the stock option on November 10, 2022 and the remaining shares vest in 24 equal monthly installments thereafter; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Issuer or otherwise ceases to serve as a director of the Issuer prior to any such vesting date. The stock option shall accelerate pursuant to the terms of the Non-Employee Director Compensation Policy of the Issuer. The stock option was granted on November 10, 2021.

Content

The stock option vests as to 1/3 of the shares subject to the stock option on November 10, 2022 and the remaining shares vest in 24 equal monthly installments thereafter; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Issuer or otherwise ceases to serve as a director of the Issuer prior to any such vesting date. The stock option shall accelerate pursuant to the terms of the Non-Employee Director Compensation Policy of the Issuer. The stock option was granted on November 10, 2021.